IMOS
ChipMOS TECHNOLOGIES Inc.
IMOS has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over IMOS overall, supported by stronger fundamentals and stronger modeled upside.
IMOS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Healthy |
IMOS's balance sheet is currently healthy. There isn't enough data to rate its revenue, profitability and cash flow.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
IMOS PE Valuation
IMOS has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
IMOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IMOS, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
IMOS Earnings Per Share
IMOS and SNDK do not have enough comparable growth data to identify a winner.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has returned to profit: it earned $125.61 per share over the past year, after losing money the year before.
IMOS Quarterly Revenue
IMOS and SNDK do not have enough comparable growth data to identify a winner.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +13 points |
| Q1 2026 | 7.5% | +5.4 points |
| Q4 2025 | 9.7% | +7.5 points |
| Q3 2025 | 6% | -0.9 points |
| Q2 2025 | 0.4% | -6.1 points |
| Q1 2025 | 2.1% | -4.6 points |
| Q4 2024 | 2.2% | -10 points |
| Q3 2024 | 6.9% | -1.8 points |
IMOS's operating margin was 13% last quarter, up 12 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over IMOS on profitability, with a higher operating margin.
IMOS Free Cash Flow
IMOS and SNDK do not have enough comparable growth data to identify a winner.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
IMOS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -40K shares |
| 1 year | -1.9% | -670K shares |
| 3 years | -3.9% | -1.4M shares |
| 5 years | -4.1% | -1.5M shares |
| Available history | -3.9% | -1.4M shares |
IMOS has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
IMOS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.0x | Net Cash |
| Q3 2024 | 0.3x | Very low |
IMOS's net debt is less than a year of its operating earnings (EBITDA).
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over IMOS on leverage, with a lower net debt burden relative to earnings.
IMOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.6 | Neutral |
| Stochastic | 17.0 | Oversold |
IMOS's weekly RSI is 47 (neutral) and its Stochastic is 17 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
IMOS PE vs Technology Sector
| Metric | IMOS | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.5% below |
| PE % | 85 | 35 | 50 pts above |
IMOS has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over IMOS on valuation relative to its sector.
IMOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 19% below |
| 20 week MA | $60.3 | 16% below |
| 50 week MA | $50.0 | 1.4% above |
| 100 week MA | $34.6 | 47% above |
| 200 week MA | $29.7 | 71% above |
IMOS has stronger trend alignment. IMOS is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
IMOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.2 | $24.0 | +3.3% |
| 2021 | $24.0 | $34.7 | +44% |
| 2022 | $34.7 | $21.4 | -38% |
| 2023 | $21.4 | $27.2 | +27% |
| 2024 | $27.2 | $19.1 | -30% |
| 2025 | $19.1 | $30.3 | +58% |
| 2026 YTD | $30.3 | $50.7 | +68% |
IMOS has finished higher in four of the last six years. It's up 68% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over IMOS on returns for 2026, with the stronger performance.